Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy Combinations Proliferating in Immuno-Oncology.

Journal of the National Cancer Institute·2022
Same author

Immune Checkpoint Inhibitors Effective in Urothelial Cancer.

Journal of the National Cancer Institute·2018
Same author

Adding radiotherapy to chemotherapy in advanced NSCLC.

The Lancet. Oncology·2017
Same author

Counterfeit and substandard malaria drugs in Africa.

The Lancet. Infectious diseases·2017
Same author

Atezolizumab in advanced non-small-cell lung cancer.

The Lancet. Oncology·2017
Same author

First-line abiraterone improves survival in prostate cancer.

The Lancet. Oncology·2017

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.8K

First Chimeric Antigen Receptor T-Cell Therapy Approved

Vicki Brower

    Journal of the National Cancer Institute
    |November 7, 2017
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
    08:46

    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

    Published on: November 12, 2019

    54.1K
    A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
    09:56

    A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

    Published on: February 21, 2025

    1.4K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
    06:18

    Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

    Published on: August 18, 2023

    3.8K
    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
    08:46

    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

    Published on: November 12, 2019

    54.1K
    A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
    09:56

    A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

    Published on: February 21, 2025

    1.4K